|
⚲
|
| Keyboard |
| Ravi Mehta | |
|---|---|
| Firm | |
| Address | 54 W 21st St Suite 301 New York, NY 10010 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Precision Neuroscience Corp | 021-527140 | Director | 93.1 M of 150.0 M |
||
| Precision Neuroscience Corp | 021-509304 | Director | 27.5 M of 45.0 M |
||
| Precision Neuroscience Corp | 021-467851 | Director | 41.2 M of 42.0 M |
||
| Steadview Targeted Fund II LP | 021-431073 | Director | 15.1 M | ||
| Steadview Capital Fund Ltd | 021-291229 | Executive Officer | 1,288.0 M | ||
| Steadview Capital Management LLC | |||||
| Steadview Targeted Fund II LP | 021-402298 | Director | 22.4 M | 15.0 M | |
| Steadview Co-Investment Opportunities Fund LP | 021-389676 | Director | 96.7 M | 131.7 M | |
| SV Targeted Co-Invest Fund I LP | 021-402298 | Director | 22.4 M | 21.1 M | |
| Steadview Capital Partners LP | 021-195826 | Executive Officer | 1,188.0 M | 110.5 M | |
| Steadview Capital Master Fund Ltd | 021-195826 | Executive Officer | 1,188.0 M | 2,250.7 M | |